The potential and challenges of using stem cells for cardiovascular repair and regeneration

被引:65
作者
Sun, Qisi [1 ]
Zhang, Zhonge [2 ]
Sun, Zhongjie [2 ]
机构
[1] Yale Univ, New Haven, CT 06520 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Physiol, Oklahoma City, OK 73104 USA
关键词
Adult stem cells; Cardiovascular disease; Embryonic stem cells; Endothelial progenitor cells; Hematopoietic stem cells; Mesenchymal stem cells; Myocardial repair; Pluripotent potent stem cells;
D O I
10.1016/j.gendis.2014.07.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent progress in using stem cells for tissue repair and functional restoration has aroused much attention due to its potential to provide a cue for many diseases such as myocardial infarction. Stem cell therapy for cardiovascular disease has been studied extensively at both experimental and clinical levels. Pluripotent stem cells and mesenchymal stem cells were proven to be effective for myocardial regeneration, angiogenesis, and cardiac functional restoration. In this review, we will concisely discuss advantages and disadvantages of currently-used stem cells for cardiovascular repair and regeneration. The limitations and uniqueness of some types of stem cells will also be discussed. Although substantial progress has been made over the last decade about stem cells in cardiovascular regeneration, many challenges lie ahead before the therapeutic potentials of stem cells can be fully recognized. Copyright (C) 2014, Chongqing Medical University. Production and hosting by Elsevier B.V. All rights reserved.
引用
收藏
页码:113 / 119
页数:7
相关论文
共 70 条
[1]   Stem cells and cardiovascular disease [J].
Abbott, JD ;
Giordano, FJ .
JOURNAL OF NUCLEAR CARDIOLOGY, 2003, 10 (04) :403-412
[2]   Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture [J].
Amit, M ;
Carpenter, MK ;
Inokuma, MS ;
Chiu, CP ;
Harris, CP ;
Waknitz, MA ;
Itskovitz-Eldor, J ;
Thomson, JA .
DEVELOPMENTAL BIOLOGY, 2000, 227 (02) :271-278
[3]  
[Anonymous], 2007, STEM CELL REPAIR REG
[4]  
[Anonymous], 2012, STEM CELL BIOL REGEN
[5]   Stem cell therapy and gene transfer for regeneration [J].
Asahara, T ;
Kalka, C ;
Isner, JM .
GENE THERAPY, 2000, 7 (06) :451-457
[6]   Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes [J].
Badorff, C ;
Brandes, RP ;
Popp, R ;
Rupp, S ;
Urbich, C ;
Aicher, A ;
Fleming, I ;
Busse, R ;
Zeiher, A ;
Dimmeler, S .
CIRCULATION, 2003, 107 (07) :1024-1032
[7]   Harnessing the Potential of Adult Cardiac Stem Cells: Lessons from Haematopoiesis, the Embryo and the Niche [J].
Balmer, Gemma M. ;
Riley, Paul R. .
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2012, 5 (05) :631-640
[8]   Is it possible to reverse the endothelial dysfunction in pulmonary arterial hypertension? Editorial comment [J].
Barst, Robyn .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (14) :1572-1574
[9]  
Bassi Enio Jose, 2011, World J Stem Cells, V3, P1, DOI 10.4252/wjsc.v3.i1.1
[10]   Adult cardiac stem cells are multipotent and support myocardial regeneration [J].
Beltrami, AP ;
Barlucchi, L ;
Torella, D ;
Baker, M ;
Limana, F ;
Chimenti, S ;
Kasahara, H ;
Rota, M ;
Musso, E ;
Urbanek, K ;
Leri, A ;
Kajstura, J ;
Nadal-Ginard, B ;
Anversa, P .
CELL, 2003, 114 (06) :763-776